Across TCGA pan-cancer cohorts, MIR1255B2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR1255B2’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR1255B2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR1255B2 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

STAD and THCA are the cancer types where MIR1255B2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR1255B2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	+0.208	.024	1	view →
THCA	All	II,III,IV	−0.148	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR1255B2 RNA expression & survival · all MIR1255B2 data types